Contentious Vote Alters Hepatitis B Vaccination Guidance

On an undisclosed date in 2023, the⁤ Advisory Committee ‌on Immunization ⁣Practices (ACIP) voted 6-4, wiht ⁣one abstention, to recommend considering ⁣antibody testing ‌after each dose of the three-dose hepatitis B vaccine series for infants. This decision‍ has drawn sharp criticism from medical‌ experts who‌ argue it lacks​ scientific basis and undermines public trust in the vaccine.

The revised recommendation suggests that if an infant’s ‍antibody ‌levels‌ reach a ‌specific threshold after a dose, subsequent doses could be skipped. This change originated from a proposal supported by members like Retsef levi, an operations management expert and ACIP member known for expressing anti-vaccine⁤ viewpoints.

Levi stated⁣ the intention behind the ⁤change may be to encourage parents to “carefully think about whether⁣ they want to take the ​risk ‍of giving another​ vaccine to⁤ their child,” possibly delaying‌ or‌ foregoing full vaccination. He suggested some parents might wait “years ‌and ⁢maybe up ​to adulthood” before completing the series.

Scientific Concerns and ‌Lack of Data

ACIP member Dr. Pablo⁤ J. Sánchez, as reported by CIDRAP, described the⁤ motivation for the change ⁤as​ “baseless skepticism.” ⁣ Numerous CDC ​subject matter experts, ​medical organizations, and committee ⁤members voiced concerns​ that there is no data to support the new recommendation.

Current vaccine ⁣efficacy data ‌is based on the ⁢completion of⁢ the‍ full three-dose series. ⁣Experts emphasize⁢ that antibody‍ levels ⁤alone are not a reliable indicator of lifelong protection against hepatitis B. ‌Dr. Sánchez, in a statement reported by CIDRAP, expressed‌ frustration, stating the ⁢vote was “like Never Never Land” and “making things up.”

Furthermore, the‍ committee did ⁣not discuss the practical challenges or costs associated with‌ routinely testing ​antibody levels ⁤in infants ‌after each vaccine dose.

Widespread Condemnation from ‌Medical Community

The decision has⁢ been met with strong ‌condemnation from medical organizations. Dr. Sandra Adamson Fryhofer, a board member of the American⁣ Medical ​association, called the vote “reckless and undermines decades of public confidence in a proven, lifesaving vaccine,” as reported ‌by⁤ the american ‍Medical Association.

fryhofer further stated that the ⁣action is “not based on scientific evidence, disregards data supporting ​the effectiveness of the Hepatitis B vaccine, and creates confusion ​for parents about how best to protect their newborns.”